U.S. Bancorp (USBC34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 80.08 |
|---|---|
| 52-week range | 60.70 – 85.95 |
| Return, 1 month / 3 months | +3.9% / −1.2% |
| Return, 1 year / 3 years | +27.0% / +127.2% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 28.7% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 0.04M BRL |
| Dividend yield | 8.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
U.S. Bancorp is a financial services company based in Minneapolis that operates through its subsidiary U.S. Bank. It provides consumer and business banking, including deposit accounts, loans, credit cards and mortgage services, along with commercial banking, payment processing and wealth management. Its customers range from individual households to small businesses, corporations and institutions across the United States, and it also offers trust and investment services through its banking and fiduciary operations.
U.S. Bancorp is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code USBC34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
U.S. Bancorp (USBC34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 80.08 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 260 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.0% and over the last three months it fell 1.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.0% | ||
| From 52-week high | -6.2% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.2% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | 22.2% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.04M BRL | ||
| Zero-volume days | 1.7% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +7.6% |
|---|---|
| 1 month | +3.9% |
| 3 months | −1.2% |
| 6 months | +15.0% |
| 1 year | +27.0% |
| 3 years | +127.2% |
| 5 years | +7.0% |
Signals
| 50-day / 200-day average | 77.64 / 74.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | USD 0.4353 |
| 30 Mar 2026 | USD 0.4298 |
| 30 Dec 2025 | USD 0.4631 |
| 29 Sep 2025 | USD 0.4690 |
| 27 Jun 2025 | USD 0.4601 |
| 28 Mar 2025 | USD 0.9683 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.